论文部分内容阅读
目的探讨液基细胞学检查筛查宫颈癌的价值。方法回顾分析本院2008年5月~2009年11月期间利用液基细胞学检查方法筛查宫颈癌的检查结果 ,宫颈细胞学检查≥ASCUS者行阴道镜下宫颈活组织检查,细胞学检查采用TBS分级系统。结果 308例液基细胞学检查的被检查者中异常者45例,发生率占14.61%,其中ASCUS 23例占7.47%;LSIL 13例,占4.22%;HSIL 7例,占2.27%;SCC2例占0.65%;细胞学诊断与组织病理学诊断符合率66.67%,宫颈癌诊断符合率100%。结论液基细胞学检查技术用于宫颈癌的筛查能明显提高宫颈异常细胞检出率,降低宫颈癌的误诊率及发病率。
Objective To investigate the value of liquid-based cytology in screening cervical cancer. Methods A retrospective analysis of our hospital from May 2008 to November 2009 using liquid-based cytology screening of cervical cancer screening results, cervical cytology ≥ ASCUS were colposcopic cervical biopsy, cytological examination using TBS classification system. Results Among the 308 patients with liquid-based cytology, 45 were abnormal, accounting for 14.61% of them, of whom 23 were ASCUS, accounting for 7.47%; LSIL 13, accounting for 4.22%; HSIL 7, accounting for 2.27%; SCC2 Accounting for 0.65%; cytology diagnosis and histopathology coincidence rate of 66.67%, diagnosis of cervical cancer coincidence rate of 100%. Conclusion Liquid-based cytological examination of cervical cancer screening can significantly improve the detection rate of cervical abnormal cells, reduce the misdiagnosis rate and incidence of cervical cancer.